PHAT vs BIIB: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Biogen Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
—
BIIB
Biogen Inc
$200.36
Key Metrics Comparison
| Metric | PHAT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $622.74M | $29.33B | BIIB |
| P/E Ratio | N/A | 21.39 | BIIB |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or BIIB a better investment?
Comparing PHAT and BIIB: Phathom Pharmaceuticals Inc has a market cap of $622.74M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and BIIB?
PHAT (Phathom Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or BIIB?
Both PHAT and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAT or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $622.74M for PHAT.
Should I buy PHAT or BIIB in 2026?
Both PHAT and BIIB have investment merit. PHAT trades at $N/A while BIIB trades at $200.36. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and BIIB stock?
Key differences: Market Cap ($622.74M vs $29.33B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAT or BIIB in 2026?
The choice between PHAT and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAT and BIIB?
PHAT (Phathom Pharmaceuticals Inc) has a market cap of $622.74M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.